A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study-Reference-Cited by-同舟云学术

A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study

Published:2020-01 Issue: Volume:299 Page:131-135
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Nashat Heba,Kempny Aleksander,Harries Carl,Dormand Natalie,Alonso-Gonzalez Rafael,Price Laura C.,Gatzoulis Michael A.,Dimopoulos Konstantinos,Wort Stephen J.

Funder

Bayer PLC

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Pulmonary vascular disease in adults with congenital heart disease;Diller;Circulation,2007

2. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension;Dimopoulos;Circulation,2010

3. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy;Tay;Int. J. Cardiol.,2011

4. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study;Galie;Circulation,2006

5. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension;Singh;Am. Heart J.,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management;International Journal of Cardiology Congenital Heart Disease;2024-09

2. Pulmonale Hypertonie bei Erwachsenen mit angeborenen Herzfehlern im Lichte der 2022-ESC-PAH-Leitlinien;Pneumologie;2024-05-24

3. Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure;Heart Failure Clinics;2024-04

4. Pulmonary Hypertension in Adults with Congenital Heart Disease;Pediatric Cardiology;2024

5. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease;Heart;2023-10-30